Strategies of Biotechnological Innovation

Strategies of Biotechnological Innovation - Theoretical Concepts, Empirical Evidence, Practical Reports

Project Management: Günter Feuerstein

Start of the Project: 01. March 2005

End of the Project: 31. Oct. 2005

Involved Institutions

Research Group Medicine/Neurosciences, FSP BIOGUM

Brief Description

In its core, the planned volume draws from a series of lectures by the same name, which were held by BIOGUM in the Winter Semester 2004-5 and also includes further supplementary contributions. The objective of the volume is to present an overview of current theoretical concepts and empirical findings as well as to sketch the foundation for an innovation’s scene in Northern Germany.

The modernization of the national policy for innovation: symbolical action or effective instrument?
A Governance for Biotechnological Innovation in International Comparison
Challenges and Problems of Utilisation Strategies • Efficient Innovation’s Policy and Management Competence in Biotechnology
Genesis and Development Supporting Regional Innovation’s Networks from Biotechnology / Medical Technique
The Roll of Social Capital in Processes of Biotechnological Innovation
Between Subvention und Market: The Fragile Existence of Younger Biotech Companies (preferable example is Hamburg)
Bay-to-bio
Norgenta: The Building and Development of Life Science Clusters in Northern Germany
MediGate: Cross-linking and Commercialisation of Clinical Research Using the Example of UKE

Publications

Feuerstein, G. (2007). Strategien biotechnischer Innovation. Analysen, Konzepte und empirische Befunde. Hamburg. Hamburg University Press, 2007